NASONEX is a clinically proven nasal spray that is used in the prevention and treatment of nasal symptoms caused by various allergies. These nasal symptoms include congestion, sneezing, itchy and runny nose and stuffiness and swelling. This medication is also used in adults who experience nasal polyps which is an abnormal growth of a nasal tissue from the mucous membranes of the nose.
NASONEX is available in the form of a nasal spray with an active ingredient that is known as mometasone furoate. The pump spray contains an aqueous suspension of the active ingredient mometasone furoate along with glycerin, microcrystalline cellulose, carboxymethycellulose sodium, sodium citrate, citric acid, benzalkonium chloride and polysorbate 80.
Benefits of NASONEX :-
Its use is recommended for symptoms of seasonal allergic and perennial allergic rhinitis both in adults and pediatric patients of 2 years of age and above. Its administration is advised about 2 – 4 weeks prior to the onset of the pollen season. Its curing effects on the nasal symptoms of allergic rhinitis have been observed within 11 hours of the first dose. It does not bring about drowsiness in the patients. The regular use of this spray does not form any sort of addiction to it and can be used as long as it has been prescribed. The liquid suspension of the spray does not involve any scent or alcohol and it does not cause deprivation of sleep either.
Side Effects of NASONEX :-
Although just like any other medication NASONEX is also accompanied by various side effects. The most common adverse effect of this drug is headache and sore throat. Also some other side effects observed in the users of NASONEX are unusual nasal bleeding, irritation or pain of the nasal cavity, blood-tinged mucus or phlegm. They may also cause allergic reactions like rash, itching, swelling, dizziness, breathing difficulties. In about 2% adult patients of allergic rhinitis certain side effects observed due to the use of this nasal spray include arthralgia, asthma, bronchitis, chest pain, conjunctivitis, diarrhea, dyspepsia, ear ache, flu-like symptoms, myalgia and nausea. Similarly, in about 2% of pediatric patients treated for allergic rhinitis the subsequent side effects involved diarrhea, nasal irritation, otitis media and wheezing.
A similar list of side effects also occurred in patients suffering from nasal polyps. In rare case studies side effects like nasal ulcers and nasal and oral candidiasis are seen. This was accompanied by nasal burning and irritation, anaphylaxis and angioedema and very rarely nasal septal perforation. Disturbance of taste and smell can also be experienced. Mometasone is a corticosteroid. It may sometimes cause acute adrenal insufficiency in patients that are initially subjected to systemic corticosteroids. When doses of intranasal corticosteroids cross the normal or if the patient has had a very recent steroid therapy, symptoms of hypercorticism occurs that may include rare cases of menstrual irregularities, acneiform lesions and cushingoid features. People who are under medication of drugs that suppress the immune system are susceptible to these side effects. Especially in patients who have not had instances of chickenpox and measles thus not immune to these diseases can have more serious effects of administration of NASONEX.
Nasal corticosteroids should be used under strict professional guidance. Patients with active or quiescent tuberculous infection of the respiratory tract or in untreated fungal, bacterial, systemic viral infections or ocular herpes simplex are strongly recommended gaining a doctor’s advice before the use of this nasal spray. Patients who have gone through cases of recent nasal septum ulcers, nasal surgery or nasal trauma should wait until they are completely cured before use of NASONEX.